Related Experiment Video
Updated: Oct 31, 2025

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Exon-Skipping in Duchenne Muscular Dystrophy.
Shin'ichi Takeda1, Paula R Clemens2, Eric P Hoffman3
1Honorary Director General, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Kodaira, Japan.
Exon skipping therapies are advancing Duchenne muscular dystrophy (DMD) treatment by restoring dystrophin protein function. This research highlights clinical progress and future directions for DMD genetic therapies.
Area of Science:
- Genetics
- Neurology
- Biomedical Research
Background:
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder.
- Understanding the genetic basis of DMD has enabled targeted therapeutic development.
- Significant progress has been made in translating genetic discoveries into clinical applications over the past 30 years.
Purpose of the Study:
- To review the clinical development of exon skipping as a therapeutic strategy for Duchenne muscular dystrophy.
- To highlight the journey from genetic understanding to clinical trials and regulatory approval.
- To outline future directions for enhancing DMD therapies.
Main Methods:
- Focus on clinical development of exon skipping strategies.
- Review of research advancements in genetic treatments for DMD.
- Analysis of therapeutic approaches to restore dystrophin protein function.
Main Results:
- Exon skipping has emerged as a central therapeutic approach for DMD.
- Clinical treatments are being utilized in patient care.
- Research is paving the way for more effective and safer future therapies.
Conclusions:
- Exon skipping represents a significant advancement in Duchenne muscular dystrophy treatment.
- Ongoing research aims to improve efficacy, safety, and address multi-systemic aspects of DMD.
- The field is progressing towards more comprehensive care for individuals with DMD.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Satellite Stem Cells and Muscular Dystrophy
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Sex-linked Disorders

